Source:http://linkedlifedata.com/resource/pubmed/id/21486701
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2011-5-30
|
pubmed:abstractText |
In this study, we compared the effects of zymosan and LPS on human monocyte-derived dendritic cells. The specific effects of zymosan on the expression of several key cytokines, including granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukins (IL-1?, IL-1? and IL-12 p70) were quite distinct from the effects of LPS. Unlike activation with LPS, DCs activated by zymosan expressed little or no IL-12 p70 due to lack of expression of the p35 subunit. However, treatment with zymosan resulted in a substantial increase in Th1 and Th17 cell-polarizing capacity of DCs. Furthermore, the GM-CSF secreted by zymosan-activated DCs enhanced IL-23 production, resulting in activation of a Th17 response. GM-CSF and IL-27, rather than IL-12 p70, were both major direct contributors to the activation of a Th1 response. This signaling mechanism is distinct and yet complementary to LPS-mediated T-cell activation. We suggest that this novel zymosan-induced GM-CSF-mediated signaling network may play a key role in regulating specific immune cell type activities.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte-Macrophage...,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Zymosan
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1096-0023
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
79-89
|
pubmed:meshHeading |
pubmed-meshheading:21486701-Biological Markers,
pubmed-meshheading:21486701-Cell Differentiation,
pubmed-meshheading:21486701-Cell Shape,
pubmed-meshheading:21486701-Cytokines,
pubmed-meshheading:21486701-Dendritic Cells,
pubmed-meshheading:21486701-Gene Expression Regulation,
pubmed-meshheading:21486701-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:21486701-Humans,
pubmed-meshheading:21486701-Lymphocyte Activation,
pubmed-meshheading:21486701-Phenotype,
pubmed-meshheading:21486701-RNA, Messenger,
pubmed-meshheading:21486701-Reproducibility of Results,
pubmed-meshheading:21486701-Th1 Cells,
pubmed-meshheading:21486701-Th17 Cells,
pubmed-meshheading:21486701-Zymosan
|
pubmed:year |
2011
|
pubmed:articleTitle |
GM-CSF plays a key role in zymosan-stimulated human dendritic cells for activation of Th1 and Th17 cells.
|
pubmed:affiliation |
Agricultural Biotechnology Research Center, Academia Sinica, Taiwan, ROC.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|